Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1

Chinese Medical Journal

Volumn 117, Issue 8, 2004, Pages 1135-1142

  Li, Yoong Jun ^a   Cui, Wei ^a   Tian, Ze Jun ^a   Hao, Yu Ming ^a   Du, Jun ^a   Liu, Fan ^a   Zhang, Hui ^a   Zu, Xiu Guang ^a   Liu, Su Yun ^a   Xie, Rui Qin ^a   Yang, Xiao Hong ^a   Wu, Yu Zhou ^a   Chen, Li ^b   An, Wei ^b  

^a Hebei Inst Cardiovasc/Cerebrovasc   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; Cytokines; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CARDIOTROPHIN 1; CELL DNA; CELL PROTEIN; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUTANT PROTEIN; SERINE; STAT3 PROTEIN; CYTOKINE; DNA BINDING PROTEIN; GLYCOPROTEIN GP 130; IL6ST PROTEIN, RAT; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN, RAT; TRANSACTIVATOR PROTEIN; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; GENETIC REGULATION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PATHOGENESIS; PROTEIN CROSS LINKING; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED DISORDER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, CD; CARDIOMEGALY; CYTOKINE RECEPTOR GP130; CYTOKINES; DNA-BINDING PROTEINS; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYROSINE;

EID: 4444246001     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yamauchi-Takihara K, Kishimoto T. Cytokines and their receptors in cardiovascular diseases - role of gp130 signaling pathway in cardiac myocyte growth and maintenance. Int J Exp Pathol 2000;81:1-16.
2. Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 2003;15:1-20.
3. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A 1995;92:1142-1146.
4. Bristow MR, Long CS. Cardiotrophin-1 in heart failure. Circulation 2002;106:1430-1432.
5. 3 in mediating the cell growth, differentiation and survival signals relayed through IL-6 family of cytokine receptors. Oncogene 2000; 19:2548-2556.
6. Railson JE, Liao Z, Brar BK, et al. Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes. Cytokine 2002;17:243-253.
7. Sheng Z, Knowlton K, Chen J, et al. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogenactivated protein kinase-dependent pathway. J Biol Chem 1997;272:5783-5791.
8. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 2000;19:2628-2637.
9. Kunisada K, Hirota H, Fujio Y, et al. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 1996;94:2626-2632.
10. Ng DCH, Long CS, Bogoyevitch MA. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 β-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J Biol Chem 2001;276:29490-29498.
11. Herzig TC, Jobe SM, Aoki H, et al. Markham. Angiotensin II typela receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure? overload. Proc Natl Acad Sci U S A 1997;94:7543-7548.
12. Minamino T, Gaussin V, DeMayo FJ, et al. Inducible gene targeting in postnatal myocardium by cardiac-specific expression of a hormone-activated cre fusion protein. Circ Res 2001;88:587-592.
13. 3 as an oncogene. Cell 1999;98:295-303.
14. Pan J, Fukuda K, Saito M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 1999;84:1127-1136.
15. Bhat G J, Abraham ST, Baker KM. Angiotensin II interferes with interleukin 6-induced stat3 signaling by a pathway involving mitogen-activated protein kinase kinase 1. J Biol Chem 1996;271:22447-22452.
16. Fukuzawa J, Booz GW, Hunt RA, et al. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through stat3 : an autocrine loop for hypertrophy. Hypertension 2000;35:1191-1196.
17. Kuwahara K, Saito Y, Harada M, et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 1999;100:1116-1124.
18. Thomas WG, Brandenburger Y, Autelitano DJ, et al. Adenoviral-directed expression of the type 1a angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 2002;90:135-142.
19. Brar BK, Stephanou A, Liao Z, et al. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc Res 2001;51:265-274.
20. Legendre F, Dudhia J, Pujol JP, et al. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes: association with a down-regulation of sox9 expression. J Biol Chem 2003;278;2903-2912.
21. David M, Petricoin E, Benjamin C, et al. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β -stimulated gene expression through STAT proteins. Science 1995; 269:1721-1723.
22. 3 serine phosphorylation by ERK-dependent and - independent pathway negatively modulates its tyrosine phosphorylation. Mol Cell Biol 1997;17:6508-6516.
23. 3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci U S A 1998;95:11107-11112.
24. 3- and SHP2-mediated signals in immune responses. Immunity 2000;12:95-105.
25. Symes A, Stahl N, Reeves SA, et al. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr Biol 1997;7:697-700.
26. Kim H, Hawley TS, Hawley RG, et al. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells, Mol Cell Biol 1998;18:1525-1533.
27. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-18632.
28. Robinson MJ, Cheng M, Khokhlatchev A, et al. Contributions of the mitogen-activated protein (MAP) kinase backbone and phosphorylation Loop to MEK specificity. J Biol Chem 1996;271:29734-29739.
29. Shimazu A, Morishita M. Basic fibroblast growth factor induces the expression of matrix metalloproteinase-3 in human periodontal ligament cells through the MEK2 mitogen-activated protein kinase pathway. J Periodontal Res 2003;38: 122-129.
30. +] i mobilization in rat basilar smooth muscle cells. Stroke 2000;31:1377-1384.
31. 3 and Ras pathways during hepatic development. Hepatology 2000;32:1370-1376.
32. Boccaccio C, Ando M, Tamagnone L, et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998;391:285-288.
33. 3 in anti-apoptosis. Immunity 1996; 5:449-460.
34. Yamanaka Y, Nakajima K, Fukada T, et al. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J 1996;15:1557-1565.